Shares of Hawkins, Inc. (NASDAQ:HWKN – Get Free Report) have been assigned an average rating of “Hold” from the five ratings firms that are currently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1 year target price among analysts that have covered the stock in the last year is $162.50.
HWKN has been the subject of a number of recent research reports. Weiss Ratings lowered Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, January 12th. Zacks Research raised Hawkins from a “strong sell” rating to a “hold” rating in a report on Friday, January 2nd. Finally, BWS Financial reissued a “buy” rating and issued a $200.00 price target on shares of Hawkins in a report on Thursday, January 29th.
View Our Latest Stock Analysis on Hawkins
Insider Activity
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently added to or reduced their stakes in HWKN. Capital World Investors raised its position in shares of Hawkins by 618.8% in the third quarter. Capital World Investors now owns 355,619 shares of the specialty chemicals company’s stock worth $64,979,000 after acquiring an additional 306,143 shares during the period. William Blair Investment Management LLC purchased a new position in shares of Hawkins in the 4th quarter valued at about $19,098,000. Wasatch Advisors LP raised its holdings in Hawkins by 31.4% in the 4th quarter. Wasatch Advisors LP now owns 552,419 shares of the specialty chemicals company’s stock worth $78,477,000 after purchasing an additional 131,850 shares during the period. Invesco Ltd. boosted its position in Hawkins by 44.4% during the third quarter. Invesco Ltd. now owns 407,793 shares of the specialty chemicals company’s stock worth $74,512,000 after purchasing an additional 125,444 shares in the last quarter. Finally, State Street Corp grew its holdings in Hawkins by 11.6% in the fourth quarter. State Street Corp now owns 1,067,451 shares of the specialty chemicals company’s stock valued at $151,642,000 after purchasing an additional 111,318 shares during the period. Hedge funds and other institutional investors own 69.71% of the company’s stock.
Hawkins Stock Down 0.9%
HWKN stock opened at $148.84 on Monday. The firm’s fifty day simple moving average is $146.60 and its 200-day simple moving average is $152.27. The company has a market capitalization of $3.11 billion, a P/E ratio of 37.68, a price-to-earnings-growth ratio of 3.18 and a beta of 0.82. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.35 and a quick ratio of 1.46. Hawkins has a 12 month low of $100.34 and a 12 month high of $186.15.
Hawkins (NASDAQ:HWKN – Get Free Report) last issued its earnings results on Wednesday, January 28th. The specialty chemicals company reported $0.72 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.75 by ($0.03). The business had revenue of $244.08 million for the quarter, compared to analysts’ expectations of $252.51 million. Hawkins had a return on equity of 16.85% and a net margin of 7.75%. As a group, equities research analysts forecast that Hawkins will post 4 earnings per share for the current year.
Hawkins Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, February 27th. Stockholders of record on Friday, February 13th were issued a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend was Friday, February 13th. Hawkins’s payout ratio is 19.24%.
Hawkins Company Profile
Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.
Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.
Further Reading
- Five stocks we like better than Hawkins
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Unlocked: Elon Musk’s Next Big IPO
- Elon Musk already made me a “wealthy man”
Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.
